Smith Hayes Advisers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $654K | Sell |
12,217
-699
| -5% | -$37.4K | 0.13% | 175 |
|
|
2015
Q4 | $848K | Sell |
12,916
-199
| -2% | -$13.1K | 0.18% | 146 |
|
|
2015
Q3 | $738K | Sell |
13,115
-549
| -4% | -$30.9K | 0.16% | 154 |
|
|
2015
Q2 | $808K | Sell |
13,664
-1,323
| -9% | -$78.2K | 0.16% | 146 |
|
|
2015
Q1 | $934K | Buy |
14,987
+3
| +0% | +$187 | 0.19% | 137 |
|
|
2014
Q4 | $862K | Sell |
14,984
-57
| -0.4% | -$3.28K | 0.18% | 145 |
|
|
2014
Q3 | $808K | Buy |
15,041
+3
| +0% | +$161 | 0.19% | 135 |
|
|
2014
Q2 | $788K | Buy |
15,038
+4
| +0% | +$210 | 0.18% | 145 |
|
|
2014
Q1 | $794K | Buy |
15,034
+204
| +1% | +$10.8K | 0.2% | 141 |
|
|
2013
Q4 | $594K | Buy |
14,830
+1,559
| +12% | +$62.4K | 0.2% | 137 |
|
|
2013
Q3 | $501K | Buy |
13,271
+224
| +2% | +$8.46K | 0.19% | 134 |
|
|
2013
Q2 | $511K | Buy |
+13,047
| New | +$511K | 0.21% | 119 |
|